The platform created by NIT Rourkela researchers is capable of delivering rapid, accurate, and repeatable imaging results with minimal human intervention
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
Transition to a fermentation-based globally integrated CDMO platform
Biologics manufacturing veteran brings over two decades of expertise in biosimilars, GMP operations, and large-scale biopharmaceutical manufacturing
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
BMS is moving beyond conversational AI into what it describes as “agentic” systems
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
The drug also delivered a disease control rate (DCR) of 83.3% in high-dose cohorts and a mean progression-free survival of 6.3 months in SCLC patients
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The global diagnostics supplier said the multi-phase expansion aims to deliver more than 60 commercially available recombinant antigen products by 2030
Subscribe To Our Newsletter & Stay Updated
